Thrombotic microangiopathy (TMA) is a group of rare disorders affecting the microvasculture of most organ beds. The impact of these diseases on those affected by them is immense. Our understanding of these disorders is rapidly expanding and therapeutic options are beginning to appear. However, many challenges remain when managing TMA and one is a practical one: the diseases are rare and the experts in them are few and spread worldwide. TalkTMA was created in order to provide a space for individuals with an interest in these disorders to network and share. It is also a space for those with questions related to TMA to get them answered.

TalkTMA was created by the same team behind other successful medical education and networking projects, most notably UKidney.com. TalkTMA is in its early launch phase and we hope to expand over time, fulfilling the needs of those learning and networking in this area.

Educational funding has been provided by Alexion Pharma Canada. All programming and development has been undertaken by a stand-alone development team which maintains no affiliation with Alexion Canada.

Dr. Jordan Weinstein - Lead Developer

TalkTMA JJW
Lead Developer

Dr. Jordan Weinstein (Director) is an internist and nephrologist at St. Michael's Hospital Toronto. His background is in medical education, web and application development. Dr. Weinstein is a veteran developer of advanced e-learning websites with special proficiency in PHP-based content management systems.

Dr. Weinstein is a nephrologist at St. Michael's Hospital in Toronto and Assistant Professor of Medicine at the University of Toronto. He serves on the educational committee of the International Society of Nephrology (ISN). Dr. Weinstein's clinical interests are in diabetic hypertension and chronic kidney disease, kidney stones and management of end-stage renal failure. Dr. Weinstein's academic portfolio is that of a clinician teacher and he has led many CMEs at a regional and national level in the areas of hypertension and chronic kidney disease. As well, he continues to serve as co investigator for clinical trials in nephrology and hypertension.

Dr. Christopher Patriquin - Lead Site Editor

TalkTMA CP
Lead Editor

Dr. Christopher Patriquin received his MD from the University of Western Ontario, where he also completed his Internal Medicine residency. He attended McMaster University for his Haematology fellowship, where he stayed on as a Clinical Scholar in complement-mediated disease. His clinical interests include the thrombotic microangiopathies (TMA) and paroxysmal nocturnal haemoglobinuria (PNH), and his M.Sc. in Health Research Methodology focussed on effective trial and observational methods in rare diseases. In 2015, Dr. Patriquin completed honorary clinical research fellowships in the United Kingdom in TMA (University College London) and PNH (NHS National PNH Service, St. James Hospital, Leeds). Dr. Patriquin is currently a member of the Canadian Apheresis Group TMA working group. In 2016, he joined the University Health Network Apheresis Unit. (Photo credit: Luke Fillion)

About Us

Thrombotic microangiopathy (TMA) is a group of rare disorders affecting the microvasculture of most organ beds. The impact of these diseases on those affected by them is immense. Our understanding of these disorders is rapidly expanding and therapeutic options are beginning to appear. However, many challenges remain when managing TMA and one is a practical one: the diseases are rare and the experts in them are few and spread worldwide. Read more...